Loading clinical trials...
Loading clinical trials...
This is a Phase 1a/1b, dose-escalation/expansion, consecutive-cohort, open-label study to evaluate the safety, tolerability, PK, PD, and preliminary evidence of antitumor activity of PLN-101095 in com...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pliant Therapeutics, Inc.
NCT06922357 · Advanced/Metastatic Solid Tumors
NCT03093116 · Locally Advanced Solid Tumors, Metastatic Solid Tumors
NCT07407504 · Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated
NCT07589530 · Advanced Solid Tumors, Metastatic Solid Tumors, and more
NCT07087197 · Metastatic Solid Tumors
Yale University
New Haven, Connecticut
South Texas Accelerated Research Therapeutics (START)
Grand Rapids, Michigan
NEXT Austin
Austin, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions